Plasma Protein-Bound Cannabinoids for Enhanced Solubility
Izun Pharmaceuticals dedicates their work to harnessing the power of natural botanical ingredients. Just this week, Izun Pharmaceuticals received a patent (US Pat. No. 10,653,787) for a water-based cannabinoid and opioid composition.
To help increase the cannabinoid’s solubility in water, it is bound to a plasma protein such as albumin. Many industries will benefit from enhancing the solubility of cannabinoids in water. For more information, check out Magic Number’s article on cannabinoid biosynthesis.
Patent ‚Äò787 is Izun Pharmaceuticals first issued patent in the sector of cannabis. To see the IP of many more companies for increasing the stability of cannabinoids, subscribe to Magic Number’s Cannabis Patent Forecast® and search the ‚ÄòCompositions – Stability’ tag.
Related Posts
Cannabis Popularity Soars Along With Tests To Detect It
The Duquenois Levine Test is used in the field by law enforcement officers to test for THC presence in a suspected sample. The problem with…
Hound Labs, Cannabix and Vox Heat Up the Marijuana Breathalyzer Market
At the start of April 2021, Patent Forecast® released an insight going over some of the big name competitors getting their foot in the door…
Cala Health Claims to Have the only Patented Neurostimulation for Essential Tremor Treatment. The Patent Data Disagrees
Cala Health has figured out that innovations backed by patents make them exponentially more valuable in the marketplace. However, in a zest…
